|
RRP1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.780300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.922380E-02 |
| Normal-vs-Stage2 |
5.640900E-03 |
| Normal-vs-Stage3 |
1.051770E-02 |
| Normal-vs-Stage4 |
3.918000E-03 |
| Stage1-vs-Stage2 |
2.782600E-01 |
| Stage1-vs-Stage3 |
5.391800E-01 |
| Stage1-vs-Stage4 |
3.607600E-01 |
| Stage2-vs-Stage3 |
5.756800E-01 |
| Stage2-vs-Stage4 |
7.488800E-01 |
| Stage3-vs-Stage4 |
7.776000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.569600E-02 |
| Normal-vs-AfricanAmerican |
1.305850E-01 |
| Normal-vs-Asian |
2.075900E-02 |
| Caucasian-vs-AfricanAmerican |
9.529400E-01 |
| Caucasian-vs-Asian |
6.656800E-01 |
| AfricanAmerican-vs-Asian |
7.156800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.056190E-03 |
| Normal-vs-Female |
1.522350E-02 |
| Male-vs-Female |
2.321800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.244500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.264560E-03 |
| Normal-vs-Age(61-80Yrs) |
1.233810E-02 |
| Normal-vs-Age(81-100Yrs) |
2.604000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.677800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.400800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.253200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.243800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.540200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.372400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.948200E-01 |
| Classical-VS-Follicular |
4.94399999828588E-08 |
| Classical-VS-Other |
2.428800E-01 |
| Classical-VS-Normal |
1.265230E-01 |
| Tall-VS-Follicular |
2.995700E-03 |
| Tall-VS-Other |
3.487200E-01 |
| Tall-VS-Normal |
2.476000E-01 |
| Follicular-VS-Other |
5.505800E-01 |
| Follicular-VS-Normal |
3.01920000000955E-07 |
| Other-VS-Normal |
8.098300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.942050E-03 |
| Normal-vs-N1 |
6.202700E-04 |
| N0-vs-N1 |
5.065600E-01 |
|
|
